Cite
HARVARD Citation
El Sahly, H. et al. (2022). Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial. Journal of infectious diseases. pp. 1731-1742. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
El Sahly, H. et al. (2022). Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial. Journal of infectious diseases. pp. 1731-1742. [Online].